Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 4/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173410 | 1.00 | HCAR2 (0.56) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL2946832 | 0.91 | HCAR2 (0.65) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL2946831 | 0.91 | HCAR2 (0.65) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL25867924 | 0.91 | HCAR2 (0.65) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL4754373 | 0.86 | HCAR2 (0.40) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL4754376 | 0.86 | HCAR2 (0.40) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL27771869 | 0.84 | HCAR2 (0.39) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL27771867 | 0.84 | HCAR2 (0.39) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL7472279 | 0.84 | HCAR2 (0.58) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL7472276 | 0.84 | HCAR2 (0.58) | HCAR2CA12AKR1B10CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119432125-A | Chitosan black talc compound for mildew prevention and antibacterial of rubber cable and preparation and application thereof | 浙江工业大学 | 2025-02-14 | — | — | CN | claimed |
| CN-118772350-A | Nanometer oil displacement agent for high-temperature high-salt oil field and preparation method thereof | 河南正佳能源环保股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| US-20180077925-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2018-03-22 | — | — | US | claimed |
| EP-3265135-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | Wilson, John Paul (US) | 2018-01-10 | — | — | EP | claimed |
| EP-1729768-B1 | IMMUNE RESPONSE MODIFIER FORMULATIONS AND METHODS | MEDA AB (SE) | 2018-01-10 | — | — | EP | claimed |
| WO-2016144907-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2016-09-15 | — | — | WO | claimed |
| WO-2013042019-A1 | PROCESS FOR PREPARING MANUFACTURED PRODUCTS IN CONGLOMERATE OF GRANULATE OF STONE MATERIAL AND RESIN WITH ANHYDRIDES FROM RENEWABLE SOURCES | TONCELLI LUCA (IT) | 2013-03-28 | — | — | WO | claimed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | claimed |
| US-20070167479-A1 | Immune response modifier formulations and methods | BAUSCH HEALTH COMPANIES INC. (CA) | 2007-07-19 | — | — | US | claimed |
| EP-1729768-A2 | IMMUNE RESPONSE MODIFIER FORMULATIONS AND METHODS | 3M Innovative Properties Company (US) | 2006-12-13 | — | — | EP | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| WO-2006099275-A2 | METHOD OF TREATING ACTINIC KERATOSIS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-09-21 | — | — | WO | claimed |
| WO-2005089317-A2 | IMMUNE RESPONSE MODIFIER FORMULATIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-09-29 | — | — | WO | claimed |
| EP-0705094-B1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PROD CO (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0705094-A4 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | AMINCO INC (US) | 1996-08-07 | — | — | EP | claimed |
| EP-0705094-A1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PRODUCTS COMPANY (US) | 1996-04-10 | — | — | EP | claimed |
| WO-1995000107-A1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | AMINCO, INC. (US) | 1995-01-05 | — | — | WO | claimed |
| EP-0224981-A2 | Nitroglycerin transdermal delivery system | PACO RESEARCH CORPORATION (US) | 1987-06-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167479-A1 | Immune response modifier formulations and methods | IFNG, TLR5, ICOS | HCAR2 288/4885CA12 3454/4885AKR1B10 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.